Alzheimer's Disease
Showing NaN - NaN of 73
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Schizophrenia, Alzheimer's Disease, Dementia Trial in San Diego (Aripiprazole, Olanzapine, Risperidone)
Completed
- Schizophrenia
- +2 more
- Aripiprazole
- +2 more
-
San Diego, CaliforniaUniversity of California, San Diego
Dec 13, 2018
Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)
Completed
- Alzheimer's Disease
- TRx0237 150 mg/day
- +2 more
-
Phoenix, Arizona
- +120 more
Mar 12, 2018
Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)
Completed
- Alzheimer's Disease
- TRx0237 200 mg/day
- Placebo
-
Phoenix, Arizona
- +94 more
Mar 12, 2018
Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)
Terminated
- Alzheimer's Disease
- Rosiglitazone XR
-
Litchfield Park, Arizona
- +271 more
Oct 11, 2017
Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)
Completed
- Alzheimer's Disease
- Rosiglitazone Extended Release 2mg
- +2 more
-
Sun City, Arizona
- +193 more
Aug 3, 2017
Alzheimer's Disease Trial in San Diego, Chicago (CERE-110: Adeno-Associated Virus Delivery of NGF)
Completed
- Alzheimer's Disease
- CERE-110: Adeno-Associated Virus Delivery of NGF
-
San Diego, California
- +1 more
Oct 27, 2016
Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)
Terminated
- Alzheimer's Disease
- Dementia
- Drug: EVP-6124
- Placebo
-
Phoenix, Arizona
- +81 more
May 2, 2016
Alzheimer's Disease Trial in Worldwide (LY450139, Placebo)
Alzheimer's Disease Trial in United States (ACC-001 (vanutide cridificar))
Completed
- Alzheimer's Disease
- ACC-001 (vanutide cridificar)
-
Sun City, Arizona
- +24 more
Dec 11, 2014